AV-Comparatives Publishes Security Survey 2026: Global Trends in Cybersecurity Adoption and Threat Perception
INNSBRUCK, Austria, Feb. 9, 2026 /PRNewswire/ -- AV-Comparatives, the leading independent authority on…
ADNOC Gas Delivers Record $5.2bn Net Income in 2025
$3.6 Billion Dividend for 2025 endorsed by BoardDomestic gas business EBITDA grew…
KuCoin to Join Consensus Hong Kong 2026, Sharing How to Turn Intelligence Into Action Through Trust-First Infrastructure
PROVIDENCIALES, Turks and Caicos Islands, Feb. 9, 2026 /PRNewswire/ -- KuCoin, a…
TradFi vs. Crypto: Bybit Launches 300,000 USDT Trading Challenge as Copy Trading Gains Momentum in Volatility
DUBAI, UAE, Feb. 9, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by…
HTX Launches Seamless USDe Minting and Redemption Service, Offering Rewards Opportunities to Holders
PANAMA CITY, Feb. 9, 2026 /PRNewswire/ -- HTX, a leading global cryptocurrency…
Waters Completes Combination with BD’s Biosciences & Diagnostic Solutions Businesses
Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms…
Avalara Appoints Dulles Krishnan as General Manager, India Operations
Veteran enterprise leader will expand his role and support the company's expansion…
IIFL Capital Receives SEBI Nod for Setting up Subsidiary at GIFT IFSC
MUMBAI, India, Feb. 9, 2026 /PRNewswire/ -- IIFL Capital Services Limited, one…
Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors
PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS…
